238 related articles for article (PubMed ID: 18378564)
1. Pharmacokinetic parameters of chlorzoxazone and its main metabolite, 6-hydroxychlorzoxazone, after intravenous and oral administration of chlorzoxazone to liver cirrhotic rats with diabetes mellitus.
Ahn CY; Bae SK; Jung YS; Lee I; Kim YC; Lee MG; Shin WG
Drug Metab Dispos; 2008 Jul; 36(7):1233-41. PubMed ID: 18378564
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of chlorzoxazone in rats with diabetes: Induction of CYP2E1 on 6-hydroxychlorzoxazone formation.
Baek HW; Bae SK; Lee MG; Sohn YT
J Pharm Sci; 2006 Nov; 95(11):2452-62. PubMed ID: 16886191
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of intravenous chlorzoxazone in rats with dehydration and rehydration: effects of food intakes.
Kim YC; Kim YG; Kim EJ; Cho MK; Kim SG; Lee MG
Biopharm Drug Dispos; 2003 Mar; 24(2):53-61. PubMed ID: 12619050
[TBL] [Abstract][Full Text] [Related]
4. Time-dependent effects of Klebsiella pneumoniae endotoxin on the pharmacokinetics of chlorzoxazone and its main metabolite, 6-hydroxychlorzoxazone, in rats: restoration of the parameters in 96 hour in KPLPS rats to control levels.
Jung HY; Kang HE; Choi YH; Kim SH; Lee MG
Biopharm Drug Dispos; 2009 Nov; 30(8):485-93. PubMed ID: 19753555
[TBL] [Abstract][Full Text] [Related]
5. Effects of cysteine on the pharmacokinetics of intravenous chlorzoxazone in rats with protein-calorie malnutrition.
Kim YG; Cho MK; Kwon JW; Kim SG; Chung SJ; Shim CK; Le Myung G
Biopharm Drug Dispos; 2002 Apr; 23(3):121-9. PubMed ID: 12173547
[TBL] [Abstract][Full Text] [Related]
6. Effects of glucose supplementation on the pharmacokinetics of intravenous chlorzoxazone in rats with water deprivation for 72 h.
Kim YC; Lee I; Kim SG; Ko SH; Lee MG; Kim SH
Life Sci; 2006 Nov; 79(23):2179-86. PubMed ID: 16914164
[TBL] [Abstract][Full Text] [Related]
7. Effects of glucose on the pharmacokinetics of intravenous chlorzoxazone in rats with acute renal failure induced by uranyl nitrate.
Ahn CY; Kim EJ; Lee I; Kwon JW; Kim WB; Kim SG; Lee MG
J Pharm Sci; 2003 Aug; 92(8):1604-13. PubMed ID: 12884247
[TBL] [Abstract][Full Text] [Related]
8. [Changes of CYP2E1 activity in diabetic rat model].
Li L; Zhang Y
Yao Xue Xue Bao; 1998 Dec; 33(12):891-5. PubMed ID: 12016852
[TBL] [Abstract][Full Text] [Related]
9. Effects of recombinant human growth hormone on the pharmacokinetics of intravenous chlorzoxazone in rats with acute renal failure induced by uranyl nitrate.
Chung W; Kim EJ; Lee I; Kim SG; Lee MG; Kim SH
Life Sci; 2003 Jun; 73(3):253-63. PubMed ID: 12757833
[TBL] [Abstract][Full Text] [Related]
10. Chlorzoxazone pharmacokinetics as a marker of hepatic cytochrome P4502E1 in humans.
Mishin VM; Rosman AS; Basu P; Kessova I; Oneta CM; Lieber CS
Am J Gastroenterol; 1998 Nov; 93(11):2154-61. PubMed ID: 9820389
[TBL] [Abstract][Full Text] [Related]
11. Obesity-induced increase of CYP2E1 activity and its effect on disposition kinetics of chlorzoxazone in Zucker rats.
Khemawoot P; Yokogawa K; Shimada T; Miyamoto K
Biochem Pharmacol; 2007 Jan; 73(1):155-62. PubMed ID: 17049493
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic changes of oltipraz after intravenous and oral administration to rats with liver cirrhosis induced by dimethylnitrosamine.
Bae SK; Lee SJ; Lee JY; Lee Y; Lee I; Kim SG; Lee MG
Int J Pharm; 2004 May; 275(1-2):227-38. PubMed ID: 15081153
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of a cytochrome P450 2E1 probe, chlorzoxazone, and its 6-hydroxy metabolite in poloxamer 407-induced hyperlipidemic rats.
Kwon MH; Lee CJ; Cho YY; Kang HE
J Pharm Pharm Sci; 2013; 16(4):648-56. PubMed ID: 24210069
[TBL] [Abstract][Full Text] [Related]
14. Effect of 1-aminobenzotriazole on the in vitro metabolism and single-dose pharmacokinetics of chlorzoxazone, a selective CYP2E1 substrate in Wistar rats.
Muzeeb S; Pasha MK; Basha SJ; Mullangi R; Srinivas NR
Xenobiotica; 2005 Aug; 35(8):825-38. PubMed ID: 16278194
[TBL] [Abstract][Full Text] [Related]
15. Impaired 6-hydroxychlorzoxazone elimination in patients with kidney disease: Implication for cytochrome P450 2E1 pharmacogenetic studies.
Nolin TD; Gastonguay MR; Bies RR; Matzke GR; Frye RF
Clin Pharmacol Ther; 2003 Dec; 74(6):555-68. PubMed ID: 14663458
[TBL] [Abstract][Full Text] [Related]
16. Effects of acute renal failure on the pharmacokinetics of chlorzoxazone in rats.
Moon YJ; Lee AK; Chung HC; Kim EJ; Kim SH; Lee DC; Lee I; Kim SG; Lee MG
Drug Metab Dispos; 2003 Jun; 31(6):776-84. PubMed ID: 12756212
[TBL] [Abstract][Full Text] [Related]
17. A study on the pharmacokinetics of chlorzoxazone in healthy Thai volunteers.
Prompila N; Wittayalertpanya S; Komolmit P
J Med Assoc Thai; 2007 Jan; 90(1):160-6. PubMed ID: 17621748
[TBL] [Abstract][Full Text] [Related]
18. In vivo CYP2E1 phenotyping as a new potential biomarker of occupational and experimental exposure to benzene.
Piccoli P; Carrieri M; Padovano L; Di Mare M; Bartolucci GB; Fracasso ME; Lepera JS; Manno M
Toxicol Lett; 2010 Jan; 192(1):29-33. PubMed ID: 19900514
[TBL] [Abstract][Full Text] [Related]
19. Effects of cytochrome P450 2E1 modulators on the pharmacokinetics of chlorzoxazone and 6-hydroxychlorzoxazone in rats.
Chen L; Yang CS
Life Sci; 1996; 58(18):1575-85. PubMed ID: 8649187
[TBL] [Abstract][Full Text] [Related]
20. Chlorzoxazone: a probe drug the metabolism of which can be used to monitor one-point blood sampling in the carbon tetrachloride-intoxicated rat.
Tanaka E
Hum Exp Toxicol; 2001 Aug; 20(8):381-5. PubMed ID: 11727787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
